Section Arrow
ASND.NASDAQ
- Ascendis Pharma A/S
Quotes are at least 15-min delayed:2025/03/28 00:16 EDT
Last
 157.94
-0.34 (-0.21%)
Day High 
161.91 
Prev. Close
158.28 
1-M High
169.37 
Volume 
265.02K 
Bid
64.57
Ask
170.68
Day Low
157.01 
Open
158.47 
1-M Low
136.57 
Market Cap 
9.51B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 162.14 
20-SMA 156.05 
50-SMA 142.97 
52-W High 169.37 
52-W Low 111.09 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.53/2.07
Enterprise Value
9.88B
Balance Sheet
Book Value Per Share
-1.91
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
363.64M
Operating Revenue Per Share
2.68
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed:2025/03/28 00:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.